Neurodevelopmental disorders and cancer networks share pathways; but differ in mechanisms, signaling strength, and outcome
Preprint
Abstract
Neurodevelopmental disorders (NDDs) and cancer are connected, with immunity as their common factor. Their clinical presentations differ; however, individuals with NDDs are more likely to acquire cancer. Schizophrenia patients have ∼50% increased risk; autistic individuals also face an increased cancer likelihood. NDDs are associated with specific brain cell types at specific locations, emerging at certain developmental time windows during brain evolution. Their related mutations are germline; cancer mutations are sporadic, emerging during life. At the same time, NDDs and cancer share proteins, pathways, and mutations. Here we ask exactly which features they share, and how despite their commonality, they differ in outcomes. Our pioneering bioinformatics exploration of the mutations, reconstructed disease-specific networks, pathways, and transcriptome profiles of autism spectrum disorder (ASD) and cancers, points to elevated signal strength in pathways related to proliferation in cancer, and differentiation in ASD. Signaling strength, not the activating mutation, is the key factor in deciding cancer versus NDDs.Keywords
All Related Versions
- Published version: npj Genomic Medicine, 8 (1), 1.
This publication has 132 references indexed in Scilit:
- The RASopathiesAnnual Review of Genomics and Human Genetics, 2013
- Sox2 Transcriptionally Regulates Pqbp1, an Intellectual Disability-Microcephaly Causative Gene, in Neural Stem Progenitor CellsPLOS ONE, 2013
- Task-related functional connectivity in autism spectrum conditions: an EEG study using wavelet transform coherenceMolecular Autism, 2013
- BRCA1-IRIS Overexpression Promotes Formation of Aggressive Breast CancersPLOS ONE, 2012
- Postmortem cardiac tissue maintains gene expression profile even after late harvestingBMC Genomics, 2012
- The Ras-ERK and PI3K-mTOR pathways: cross-talk and compensationTrends in Biochemical Sciences, 2011
- PathCluster: a framework for gene set-based hierarchical clusteringBioinformatics, 2008
- PTEN Nuclear Localization Is Regulated by Oxidative Stress and Mediates p53-Dependent Tumor SuppressionMolecular and Cellular Biology, 2008
- JUN Oncogene Amplification and Overexpression Block Adipocytic Differentiation in Highly Aggressive SarcomasCancer Cell, 2007
- Crystal Structure of the PTEN Tumor SuppressorCell, 1999